Dr. David Richard Wyndhamsmith, MD

Dr. Wyndhamsmith practices at Adventist Health Glendale in Glendale, California, part of Adventist Health.

Dr. Wyndhamsmith's NPI, 1407879596, was assigned on July 26, 2006. Dr. Wyndhamsmith graduated from Keck School of Medicine of USC in 1990. Dr. Wyndhamsmith holds California license G72018.

Dr. Wyndhamsmith's primary practice is Adventist Health Glendale, at 1509 E Wilson Terrace, Glendale, CA 91206 in Los Angeles County. The practice phone is (818) 409-8202.

Dr. Wyndhamsmith's primary practice is Adventist Health Glendale in Glendale, California, part of Adventist Health. The medical group on file is Adventist Health Glendale. Dmand AI also links Dr. Wyndhamsmith to 3 more medical groups, each named with a free account. Dr. Wyndhamsmith's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wyndhamsmith practices. Vendor and product names are available with a free account.

Anesthesiology is Dr. Wyndhamsmith's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Wyndhamsmith is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Wyndhamsmith's licenses on file in 2 states: California and Nevada.

CMS data shows 12 Medicare services from Dr. Wyndhamsmith across 1 procedure code in 2024, for 83 Medicare patients. Medicare paid $424 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 83 Medicare patients who saw Dr. Wyndhamsmith in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have arthritis, and 75% have high blood pressure. 73% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wyndhamsmith's median patient age at 62, with 56% women.

In 2024, Dr. Wyndhamsmith wrote 150 Medicare Part D claims for 79 patients. 100% of them were for generic drugs. CMS names the drug for 116 of them, across 2 drugs with 11 or more claims each, at $615 in total drug cost. In 2023, CMS named 89 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Wyndhamsmith for performance year 2024, reported as part of a group. Dr. Wyndhamsmith accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 38 general payments to Dr. Wyndhamsmith from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Straumann USA LLC paid the most, $1,580.

Dr. Wyndhamsmith graduated from Keck School of Medicine of USC in 1990.

Dr. Wyndhamsmith is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.